Brendan J. Nolan

Jul 15, 2024 | healio.com | Regina Schaffer |Richard Smith |Joshua D. Safer |Brendan J. Nolan

Joshua D. Safer, MD, FACP, FACE Although it is interesting to confirm that the dosing needs reported initially for some patients correlate with the needs of those same patients later, there are several important caveats. While it seems that the number is increasing of people reporting that they are nonbinary, how people label themselves may not correlate tightly with gender-affirming treatment needs.

Jun 3, 2024 | healio.com | Regina Schaffer |Richard Smith |Brendan J. Nolan

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Most nonbinary people who initiated low-dose testosterone therapy were still not taking a full dose by 12 months. People identifying as nonbinary may desire a slower or lower degree of physical changes.